|
|
41
|
|
|
A5213
|
|
|
SURVANTA 25MG/ML INJ (ABB) BERACTANT (BQ)
|
|
|
BERACTANT
|
|
|
SURVANTA
|
|
|
8ML VIAL
|
|
|
BQ
|
|
|
1042.4
|
|
|
1042.3957
|
|
|
25MG/ML
|
|
|
VIAL
|
|
|
50
|
|
|
VIAL
|
|
|
ABB
|
|
|
ABBOTT
|
|
|
PHA
|
|
|
PHARMACY SALES CARIBBEAN
|
|
|
|
|
|
|
|
|
2024-04-01
|
|
|
2026-03-31
|
|
|
|
|
|
|
|
|
|
|
|
0
|
|
|
N
|
|
|
4836
|
|
|
PULMONARTY SURFCTANTS
|
|
|
|
|
|
IV
|
|
|
0
|
|
|
PULMONARTY SURFCTANTS
|
|
|
|